Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
Laura Vandenberg is at School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USAJudith Turgeon is at University of California - Davis, CA, USA
Inhaltsangabe
Preface Laura N. Vandenberg and Judith L. Turgeon 1. Endocrine disruptor global policy Christopher D. Kassotis and Leonardo Trasande 2. Toxicity testing and endocrine disrupting chemicals Laura N. Vandenberg 3. Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain Madeline Streifer and Andrea C. Gore 4. Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid Heather B. Patisaul 5. Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models Mary Jo Laws, Alison M. Neff, Emily Brehm, Genoa R. Warner and Jodi A. Flaws 6. Endocrine disrupting chemicals (EDCs) and sex steroid receptors Julianne M. Hall and Kenneth S. Korach 7. Endocrine disrupting chemicals and the mammary gland Laura N. Vandenberg 8. Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes Vasantha Padmanabhan, Jacob Moeller and Muraly Puttabyatappa 9. Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development William P. Marinello and Heather B. Patisaul 10. Endocrine disrupting chemicals and thyroid hormone action R. Thomas Zoeller 11. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic Margaret C. Schulz and Robert M. Sargis 12. The new kids on the block: Emerging obesogens Raquel Chamorro-Garcia and Almudena Veiga-Lopez 13. Endocrine disrupting chemicals and breast cancer cells Philippa D. Darbre 14. EDCs and male urogenital cancers M.S. Bornman and N.H. Aneck-Hahn
Preface Laura N. Vandenberg and Judith L. Turgeon 1. Endocrine disruptor global policy Christopher D. Kassotis and Leonardo Trasande 2. Toxicity testing and endocrine disrupting chemicals Laura N. Vandenberg 3. Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain Madeline Streifer and Andrea C. Gore 4. Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid Heather B. Patisaul 5. Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models Mary Jo Laws, Alison M. Neff, Emily Brehm, Genoa R. Warner and Jodi A. Flaws 6. Endocrine disrupting chemicals (EDCs) and sex steroid receptors Julianne M. Hall and Kenneth S. Korach 7. Endocrine disrupting chemicals and the mammary gland Laura N. Vandenberg 8. Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes Vasantha Padmanabhan, Jacob Moeller and Muraly Puttabyatappa 9. Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development William P. Marinello and Heather B. Patisaul 10. Endocrine disrupting chemicals and thyroid hormone action R. Thomas Zoeller 11. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic Margaret C. Schulz and Robert M. Sargis 12. The new kids on the block: Emerging obesogens Raquel Chamorro-Garcia and Almudena Veiga-Lopez 13. Endocrine disrupting chemicals and breast cancer cells Philippa D. Darbre 14. EDCs and male urogenital cancers M.S. Bornman and N.H. Aneck-Hahn
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG i.I. Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
